Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9

A Pseudomonas aeruginosa purification method technology, applied in the field of biopharmaceuticals, can solve the problems of recombinant protein Vac9 purification methods and reports that have not yet been seen, and achieve good immune protection, good repeatability, and high humoral immune response.

Inactive Publication Date: 2016-06-01
ARMY MEDICAL UNIV
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the purification method for the recombinant protein Vac9

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9
  • Method for purifying pseudomonas aeruginosa vaccine recombinant protein Vac 9

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1: Cloning of OprL gene and construction of recombinant plasmid pGEX-6P-2-OprL

[0065] 1. Firstly, according to the full-length gene sequence of the OprL protein of Pseudomonas aeruginosa PA01, bioinformatics software was used for structural analysis to determine the OprL target gene fragment to be amplified.

[0066] 2. According to the analysis results, the PCR method was used to amplify the OprL target gene fragment from the PA01 genome, and the amplification steps were as follows:

[0067] 1) Design the PCR primers as follows, which are SEQ ID NO: 3-4 (the base sequence of the restriction site is underlined)

[0068] Seq ID

Primer name

Sequence (5'-3')

Endonuclease

Seq ID 3

OprL-F

CGC GGATCC TGCTCCTCCAAGGGCG

Bam H I

Seq ID 4

OprL-R

CCG GAATTC TTACTTCTTCAGCTCGACG

EcoR I

[0069] 2) Take out the preserved Pseudomonas aeruginosa strain PA01 from the -80°C freezer and spread it on LB s...

Embodiment 2

[0098] Example 2: Identification of recombinant fusion protein Vac9 induced expression and expression form in prokaryotic expression system-Escherichia coli

[0099] 1. Induced expression of recombinant protein Vac9

[0100]Take 100 μL of the overnight cultured pGEX-6P-2-OprL / XL-1blue bacterial solution and add it to 10 mL of Amp+ resistant LB medium, culture overnight at 180 rpm at 37°C, respectively take 400 μL of the overnight cultured bacterial solution and add it to 20 mL of Amp+ resistant LB medium (The rest of the bacterial solution is stored in a refrigerator at 4°C for later use), culture at 37°C for 2-3 hours, rotate at 200 rpm, and reactivate until the OD600 is 0.8-1.0, add 4 μL of IPTG to make the final concentration 200 μM, and place on a shaker Induced expression Induced expression at 30°C for 3h.

[0101] 2) Take out the bacterial solution after induced expression, centrifuge at 12000rpm for 5min, discard the supernatant, add 1mL of lysisbuffer (20mMPB, pH7.2, ...

Embodiment 3

[0108] Embodiment 3: Preparation of recombinant protein Vac9 antigen

[0109] 1. Amplify culture to obtain protein

[0110] Take 400 μL of the pGEX-6P-2-OprL / XL-1blue bacterial solution stored in the refrigerator at 4°C and add it to 20mL LB medium containing Amp resistance for one activation. After culturing at 200rpm for 5-6 hours at 37°C, take 8mL once The activated bacterial solution was added to 400mL LB medium containing Amp resistance for secondary activation, cultured at 37°C for 3-4h until the OD600 was 1.0, then added 80μLPTG (final concentration 200μM) and placed in a shaker at 16°C overnight to induce Afterwards, 12000rpm centrifugal 15min collects thalline, adds 20mLlysisbuffer (same as embodiment 2) after resuspending thalline, bacterium liquid is carried out ultrasonic cracking 3min (200V), collect supernatant and GlutathioneSepharose4B (GE Company) gel beads (beads) binding treatment; then SDS-PAGE gel electrophoresis.

[0111] 2. Use the enzyme digestion met...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for purifying pseudomonas aeruginosa (PA) recombinant subunit genetic engineering protein vaccine Vac 9. The Vac 9 protein is obtained in the mode that pseudomonas aeruginosa cell outer membrane protein is recombined and confused, and escherichia coli genetically engineered bacterium expression is conducted. Technologies including high pressure bacterium breaking, GST affinity chromatography, Prescission Protease (PP enzyme) restriction enzyme digestion, Phenyl HP chromatography, G25 chromatography, Q HP endotoxin removal and the like are conducted on genetic engineering bacteria, and the high-purity pseudomonas aeruginosa (PA) recombinant subunit genetic engineering protein vaccine Vac 9 is obtained. The method is simple and fast in purifying process, easy to amplify and good in repeatability, the obtained target protein is high in purity, the production requirements of genetic engineering vaccines can be met, and it is proved by animal tests that a mechanism can be effectively stimulated to generate high humoral immune response and a good immune protective effect.

Description

technical field [0001] The invention belongs to the field of biopharmaceuticals, in particular to a method for purifying the recombinant protein Vac9 (OprL) of Pseudomonas aeruginosa (PA) vaccine. Background technique [0002] Pseudomonas aeruginosa (Pseudomonas aeruginosa, PA), commonly known as Pseudomonas aeruginosa, belongs to the genus Pseudomonas in non-fermenting bacteria. It is ubiquitous and is one of the most common opportunistic pathogens in clinical practice. Due to the high clinical infection rate of PA and the rising rate of drug resistance, it is imminent to find new "non-antibiotic therapy". From the perspective of immunology, it is the most ideal choice to develop a safe and effective vaccine. [0003] OprL is a peptidoglycan associated lipoprotein of Pseudomonas aeruginosa, which is located in the outer membrane of Pseudomonas aeruginosa and plays an important role in the physiological and pathological processes of bacteria. OprL protein is highly conserv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/21C12N15/31C07K1/22C07K1/16
CPCC07K14/21
Inventor 敬海明顾江邹全明章金勇孙红武付强牟道华张玉东徐丽敏
Owner ARMY MEDICAL UNIV
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More